Market Closed -
OTC Markets
09:30:03 2024-03-07 am EST
|
5-day change
|
1st Jan Change
|
0.0006
USD
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscal Period: July |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Capitalization
1 |
1.986
|
0.5206
|
6.247
|
53.15
|
33.76
|
79.43
|
Enterprise Value (EV)
1 |
2.089
|
0.6234
|
6.323
|
53.37
|
41.43
|
90.18
|
P/E ratio
|
-1.32
x
|
-107
x
|
-48.4
x
|
-27.7
x
|
-4.26
x
|
-9.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
209,218,573
x
|
1,939,421,009
x
|
EV / Revenue
|
-
|
-
|
-
|
-
|
256,713,362
x
|
2,202,011,623
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-6,426,808
x
|
-12,485,533
x
|
EV / FCF
|
565
x
|
371
x
|
124
x
|
100
x
|
215
x
|
-167
x
|
FCF Yield
|
0.18%
|
0.27%
|
0.81%
|
1%
|
0.46%
|
-0.6%
|
Price to Book
|
-10.1
x
|
-2.46
x
|
-18.3
x
|
-83.1
x
|
-7.79
x
|
-11.6
x
|
Nbr of stocks (in thousands)
|
33,108
|
34,708
|
34,708
|
36,658
|
38,696
|
44,126
|
Reference price
2 |
0.0600
|
0.0150
|
0.1800
|
1.450
|
0.8725
|
1.800
|
Announcement Date
|
6/8/18
|
6/22/18
|
11/13/18
|
11/13/19
|
10/29/20
|
11/19/21
|
Fiscal Period: July |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Net sales
|
-
|
-
|
-
|
-
|
0.1614
|
0.041
|
EBITDA
|
-
|
-
|
-
|
-
|
-6.446
|
-7.223
|
EBIT
1 |
-0.007188
|
-0.002029
|
-0.166
|
-1.819
|
-6.524
|
-7.398
|
Operating Margin
|
-
|
-
|
-
|
-
|
-4,042.8%
|
-18,064.31%
|
Earnings before Tax (EBT)
1 |
-1.573
|
-0.00487
|
-0.1291
|
-1.844
|
-7.728
|
-8.391
|
Net income
1 |
-1.573
|
-0.00487
|
-0.1291
|
-1.844
|
-7.728
|
-8.391
|
Net margin
|
-
|
-
|
-
|
-
|
-4,789.03%
|
-20,489.68%
|
EPS
2 |
-0.0455
|
-0.000140
|
-0.003719
|
-0.0524
|
-0.2046
|
-0.1978
|
Free Cash Flow
1 |
0.003698
|
0.001681
|
0.0509
|
0.5336
|
0.1925
|
-0.5398
|
FCF margin
|
-
|
-
|
-
|
-
|
119.29%
|
-1,318%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/8/18
|
6/22/18
|
11/13/18
|
11/13/19
|
10/29/20
|
11/19/21
|
Fiscal Period: July |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Net Debt
1 |
0.1
|
0.1
|
0.08
|
0.21
|
7.66
|
10.8
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-1.189
x
|
-1.489
x
|
Free Cash Flow
1 |
0
|
0
|
0.05
|
0.53
|
0.19
|
-0.54
|
ROE (net income / shareholders' equity)
|
771%
|
2.33%
|
46.8%
|
376%
|
305%
|
149%
|
ROA (Net income/ Total Assets)
|
-153%
|
-44.9%
|
-6,212%
|
-409%
|
-153%
|
-85.4%
|
Assets
1 |
1.026
|
0.0108
|
0.002078
|
0.4505
|
5.044
|
9.821
|
Book Value Per Share
2 |
-0.0100
|
-0.0100
|
-0.0100
|
-0.0200
|
-0.1100
|
-0.1600
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0.0100
|
Capex
|
-
|
-
|
-
|
0.25
|
0.22
|
0.38
|
Capex / Sales
|
-
|
-
|
-
|
-
|
135.45%
|
919.88%
|
Announcement Date
|
6/8/18
|
6/22/18
|
11/13/18
|
11/13/19
|
10/29/20
|
11/19/21
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 26.69K | | +86.83% | 283M | | +51.55% | 268M | | +69.77% | 195M | | +89.13% | 130M | | +117.66% | 121M | | -14.29% | 121M | | +23.08% | 87.06M | | +150.00% | 75.33M | | -6.02% | 52.1M |
Medical Farming
|